These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24146185)

  • 1. Quantification of clusterin in paired cerebrospinal fluid and plasma samples.
    Jongbloed W; Herrebout MA; Blankenstein MA; Veerhuis R
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):557-67. PubMed ID: 24146185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.
    Nilselid AM; Davidsson P; Nägga K; Andreasen N; Fredman P; Blennow K
    Neurochem Int; 2006 Jun; 48(8):718-28. PubMed ID: 16490286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease.
    van Dijk KD; Jongbloed W; Heijst JA; Teunissen CE; Groenewegen HJ; Berendse HW; van de Berg WD; Veerhuis R
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1079-83. PubMed ID: 23932065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab.
    Lachno DR; Evert BA; Vanderstichele H; Robertson M; Demattos RB; Konrad RJ; Talbot JA; Racke MM; Dean RA
    J Alzheimers Dis; 2013; 34(4):897-910. PubMed ID: 23302661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies.
    Lachno DR; Romeo MJ; Siemers ER; Vanderstichele H; Coart E; Konrad RJ; Zajac JJ; Talbot JA; Jensen HF; Sethuraman G; Demattos RB; May PC; Dean RA
    J Alzheimers Dis; 2011; 26(3):531-41. PubMed ID: 21694458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    Vishnu VY; Modi M; Sharma S; Mohanty M; Goyal MK; Lal V; Khandelwal N; Mittal BR; Prabhakar S
    PLoS One; 2016; 11(11):e0166369. PubMed ID: 27861589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease.
    Xing YY; Yu JT; Cui WZ; Zhong XL; Wu ZC; Zhang Q; Tan L
    J Alzheimers Dis; 2012; 29(3):515-9. PubMed ID: 22258514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.
    Deming Y; Xia J; Cai Y; Lord J; Holmans P; Bertelsen S; Holtzman D; Morris JC; Bales K; Pickering EH; Kauwe J; Goate A; Cruchaga C;
    Neurobiol Aging; 2016 Jan; 37():208.e1-208.e9. PubMed ID: 26545630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis.
    Shi X; Xie B; Xing Y; Tang Y
    Curr Alzheimer Res; 2019; 16(11):1018-1027. PubMed ID: 31647395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?
    Sancesario GM; Esposito Z; Nuccetelli M; Bernardini S; Sorge R; Martorana A; Federici G; Bernardi G; Sancesario G
    Exp Neurol; 2010 Jun; 223(2):371-6. PubMed ID: 19664624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.
    Vanderstichele H; Van Kerschaver E; Hesse C; Davidsson P; Buyse MA; Andreasen N; Minthon L; Wallin A; Blennow K; Vanmechelen E
    Amyloid; 2000 Dec; 7(4):245-58. PubMed ID: 11132093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No correlation between time-linked plasma and CSF Abeta levels.
    Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma clusterin and the risk of Alzheimer disease.
    Schrijvers EM; Koudstaal PJ; Hofman A; Breteler MM
    JAMA; 2011 Apr; 305(13):1322-6. PubMed ID: 21467285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
    Jongbloed W; Kester MI; van der Flier WM; Veerhuis R; Scheltens P; Blankenstein MA; Teunissen CE
    Alzheimers Dement; 2013 May; 9(3):276-83. PubMed ID: 23110867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Quantification of Neurotrophic Adipokines RBP4, PEDF, and Clusterin in Human Cerebrospinal Fluid and Serum.
    Höpfinger A; Berghoff M; Karrasch T; Schmid A; Schäffler A
    J Clin Endocrinol Metab; 2021 Apr; 106(5):e2239-e2250. PubMed ID: 33484131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No diagnostic value of plasma clusterin in Alzheimer's disease.
    Silajdžić E; Minthon L; Björkqvist M; Hansson O
    PLoS One; 2012; 7(11):e50237. PubMed ID: 23209684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.
    Koel-Simmelink MJ; Vennegoor A; Killestein J; Blankenstein MA; Norgren N; Korth C; Teunissen CE
    J Immunol Methods; 2014 Jan; 402(1-2):43-9. PubMed ID: 24275679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
    Song L; Lachno DR; Hanlon D; Shepro A; Jeromin A; Gemani D; Talbot JA; Racke MM; Dage JL; Dean RA
    Alzheimers Res Ther; 2016 Dec; 8(1):58. PubMed ID: 27978855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.